A deficiency might lead to skin issues like premature aging, dryness, or increased susceptibility to damage
Legal Status / FDA BPC-157 occupies a complex regulatory gray area
The use of mice lacking NKCC1 specifically in insulin-secreting -cells (NKCC1 KO ) has provided some insight into the long-term metabolic effects of the bumetanide-sensitive NKCC1 in insulin secreting cells
Together, these foods help you eat for satiety, elongate your blood sugar curve, burn fat, and lower inflammation
The effect of 2-AMP-BPC157 on bleeding time in mice and rats (with and without heparin pre-treatment) was investigated in conjunction with the in vitro activity on clotting parameters in human blood
References Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds